Elektrofi

Acquired

Formulating the future of biologics.

Boston, United States · Founded 2016 · $152.3M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$152.3M
Last Round
$112.3M Series COct 2024
Rounds
2
Acquired by
Halozyme TherapeuticsOct 2025

About

Elektrofi is a biopharmaceutical formulation technology company revolutionizing the delivery of biologic therapies by enabling subcutaneous administration of medicines traditionally given intravenously. Using its proprietary Hypercon microparticle platform, Elektrofi partners with biopharmaceutical companies to develop hyper-concentrated, stable formulations of monoclonal antibodies and therapeutic proteins, giving patients more convenient treatment options.

Summary

Elektrofi is a Life Sciences company based in Boston, United States, founded in 2016. It has raised $152.3M in total across 2 rounds, most recently a $112.3M Series C round in Oct 2024. Investors include RA Capital Management, Royalty Pharma and SR One.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionOct 2025
$750.0M

Sign up to see all 3 rounds

Series B through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Elektrofi on Indexed.vc
<a href="https://indexed.vc/companies/elektrofi"><img src="https://indexed.vc/api/badge/company/elektrofi" alt="Elektrofi on Indexed.vc" width="260" height="76" /></a>